Italy: Chiesi appoints Accogli as new Group CEO

Following an extensive international search process, Chiesi Farmaceutici, the international research-focused biopharmaceutical group, has appointed Giuseppe Accogli as new group CEO. He takes up the position on April 3, 2023. Accogli has 25 years of international experience in the med-tech sector in companies such as Baxter and Medtronic. He brings a strong background across multiple operational…

You must be a HMI Subscriber to view this content.

Subscribe Now »